NuSkin Enterprises (NUS)

NYSE Mercato chiuso

Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.

Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.

Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.

The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.

5.37 USD
5.19 USD
+0.05 (+0.94%)
Fuori orario

Ultimo aggiornamento

Capitalizzazione
258.29M
P/U
4.74
P/FCF operativo
6.21
P/Ricavi
0.18
Valore d'impresa
283.23M
Settore
Health Care
Settore industriale
Drugs, Drug Proprietaries, and Druggists' Sundries
Indirizzo
75 WEST CENTER ST, PROVO, UT, 84601
GlobeNewswire Inc.

Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%

10 set 2024, 00:00 AM
Zacks Investment Research

Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?

07 giu 2024, 17:30 PM
Zacks Investment Research

Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

09 mag 2024, 16:23 PM
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates

09 mag 2024, 01:00 AM
Zacks Investment Research

Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?

28 mar 2024, 16:30 PM
Zacks Investment Research

Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?

15 mar 2024, 16:30 PM
Zacks Investment Research

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

15 feb 2024, 13:51 PM
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

15 feb 2024, 00:20 AM
Zacks Investment Research

Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings

12 feb 2024, 13:49 PM
Zacks Investment Research

Philip Morris (PM) Lags Q4 Earnings Estimates

08 feb 2024, 14:15 PM
Zacks Investment Research

Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

07 feb 2024, 16:00 PM
Zacks Investment Research

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

13 dic 2023, 18:50 PM
Zacks Investment Research

Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?

07 dic 2023, 17:31 PM
Zacks Investment Research

Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?

01 dic 2023, 17:32 PM
Zacks Investment Research

Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance

02 nov 2023, 16:44 PM
Zacks Investment Research

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

30 ott 2023, 17:10 PM
Zacks Investment Research

e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?

30 ott 2023, 16:05 PM
Zacks Investment Research

Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings

30 ott 2023, 14:06 PM
Zacks Investment Research

Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

25 ott 2023, 16:02 PM
Zacks Investment Research

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

10 ott 2023, 15:10 PM
Capitalizzazione
258.29M
Valore d'impresa
283.23M
P/U
4.74
P/VL
0.33
P/Ricavi
0.18
Valore d'impresa / EBITDA
2.15
EV / Ricavi
0.2
Utile per azione
1.12
Rendimento del dividendo
7.05%
P/FCF operativo
6.21
P/Flusso di cassa
3.4
Free cash flow
41.57M
ROE (rend. patrimonio)
6.87%
ROA (rend. attivo)
3.96%
Debito / Patrimonio netto
0.28
Indice di liquidità corrente
2.03
Indice di liquidità rapida
1.34
Liquidità
0.77
Vol. medio
647.09K
Prezzo di riferimento fondamentale
5.32

Conto economico

Voce 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Ricavi 320.61M 370.32M 364.21M 386.14M 364.49M
Utile lordo 214.46M 261.98M 256.72M 265.73M 246.96M
Risultato operativo 4.03M 23.24M 21.64M 30.78M -9.9M
MOL 18.21M 36.16M 33.73M 43.83M 29.42M
Utile netto 1.84M 14.49M 17.08M 21.12M 107.52M
EPS base 0.04 0.31 0.35 0.43 2.16
EPS diluito 0.04 0.27 0.34 0.43 2.14

Stato patrimoniale

Voce 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Attivo totale 1.38B 1.41B 1.42B 1.44B 1.39B
Passivo totale 582.71M 600.07M 624.61M 655.94M 637.44M
Patrimonio netto 794.09M 805.24M 799.8M 787.75M 753.97M
Liquidità e equivalenti 198.65M 238.63M 251.79M 264.16M 203.77M
Attivo corrente 522.89M 547.7M 548.14M 571.55M 524.86M
Passivo corrente 257M 263.73M 254.44M 283.91M 260.3M

Flusso di cassa

Voce 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Flusso di cassa operativo -3.92M 16.62M 27.48M 35.8M 389K
Flusso di cassa da investimenti -14.29M -9.76M -9.92M 8.79M 181.54M
Flusso di cassa da finanziamenti -20.4M -18.5M -26.88M 9.27M -166.3M
Variazione di liquidità -39.98M -13.16M -12.37M 60.39M 16.89M
Tipo Documento Data Collegamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 144 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 4 Form 4 — Winett James M Visualizza documento
edgar index S-8 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 144 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 4 Form 4 — CAMPBELL DANIEL W Visualizza documento
form 4 Form 4 — CAMPBELL DANIEL W Visualizza documento
form 4 Form 4 — CAMPBELL DANIEL W Visualizza documento
form 4 Form 4 — Thomas Pisano R. Visualizza documento
form 4 Form 4 — Battle Emma S. Visualizza documento
form 4 Form 4 — WOODBURY EDWINA D Visualizza documento
form 4 Form 4 — WOODBURY EDWINA D Visualizza documento
form 4 Form 4 — Zorko Mark A Visualizza documento
form 4 Form 4 — Nathanson Laura Visualizza documento
form 4 Form 4 — Winett James M Visualizza documento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Visualizza documento
eight k text 8-K — 8-K Visualizza documento
edgar index SD — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 144 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 4 Form 4 — Nathanson Laura Visualizza documento
edgar index 10-Q — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Visualizza documento
eight k text 8-K — 8-K Visualizza documento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Visualizza documento
eight k text 8-K — 8-K Visualizza documento
edgar index DEF 14A — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index DEFA14A — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index ARS — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 3 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 3 Form 3 — Lantz Chelsea K Visualizza documento
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Visualizza documento
eight k text 8-K — 8-K Visualizza documento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Visualizza documento
eight k text 8-K — 8-K Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 4 Form 4 — WOODBURY EDWINA D Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Visualizza documento
eight k text 8-K — 8-K Visualizza documento
form 4 Form 4 — NAPIERSKI RYAN S Visualizza documento
form 4 Form 4 — Thomas James D Visualizza documento
form 4 Form 4 — Clark Chayce David Visualizza documento
form 4 Form 4 — Hatchett Steven Keith Visualizza documento
form 4 Form 4 — Keisel Justin S Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 4 Form 4 — NAPIERSKI RYAN S Visualizza documento
form 4 Form 4 — Thomas James D Visualizza documento
form 4 Form 4 — Clark Chayce David Visualizza documento
form 4 Form 4 — Hatchett Steven Keith Visualizza documento
form 4 Form 4 — Keisel Justin S Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
edgar index 4 — NU SKIN ENTERPRISES, INC. Visualizza documento
form 4 Form 4 — NAPIERSKI RYAN S Visualizza documento
form 4 Form 4 — Thomas James D Visualizza documento
form 4 Form 4 — Clark Chayce David Visualizza documento